ID: ALA5279354

Max Phase: Preclinical

Molecular Formula: C5H6N6S4

Molecular Weight: 278.41

Associated Items:

Representations

Canonical SMILES:  S=c1[nH]nc(NCNc2n[nH]c(=S)s2)s1

Standard InChI:  InChI=1S/C5H6N6S4/c12-4-10-8-2(14-4)6-1-7-3-9-11-5(13)15-3/h1H2,(H,6,8)(H,7,9)(H,10,12)(H,11,13)

Standard InChI Key:  RSNWORHVUOZYLT-UHFFFAOYSA-N

Associated Targets(non-human)

Xanthomonas oryzae pv. oryzae 79 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 278.41Molecular Weight (Monoisotopic): 277.9537AlogP: 2.20#Rotatable Bonds: 4
Polar Surface Area: 81.42Molecular Species: NEUTRALHBA: 8HBD: 4
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.96CX Basic pKa: 0.74CX LogP: 2.22CX LogD: 1.59
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.51Np Likeness Score: -0.93

References

1. Aggarwal R, Sumran G..  (2020)  An insight on medicinal attributes of 1,2,4-triazoles.,  205  [PMID:32771798] [10.1016/j.ejmech.2020.112652]

Source